BP002843-HCV-269: Recombinant Hepatitis C Virus NS5B (HCV NS5B) Protein
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity > 95% pure as determined by SDS-PAGE.
Applications: ELISA, WB.BP000421-HCV-236: Recombinant HCV NS5, Biotin
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-263: Recombinant HCV NS5, Horseradish Peroxidase
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-206: Recombinant HCV NS5 Genotype-1a (2322-2423)
Source: E. coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-219: Recombinant HCV NS5 Genotype-1
Source: E. coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-227: Recombinant HCV NS5 Genotype-1a
Source: E. coli-derived.
Specificity:Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-228: Recombinant HCV NS5 Genotype-1b
Source: E. coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-229: Recombinant HCV NS5 Genotype-2
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-230: Recombinant HCV NS5 Genotype-2a
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.BP000421-HCV-231: Recombinant HCV NS5 Genotype-2b
Source: E.coli-derived.
Specificity: Immunoreactive with sera of HCV-infected individuals.
Purity>95% by 10% PAGE.
Applications: ELISA, WB.